Warrant Exercise, Director Shareholdings & Options | Company Announcement | Investegate
Fundraise
Welcome
Articles
About
Contact Us
Help
Home
Companies
Advanced search
Archive
Meetings
UK Newswire
New
Login
Register
Warrant Exercise, Director Shareholdings & Options
Summary by AI
BETA
Close X
Arkle Resources PLC announced the exercise of 16,000,000 warrants by Directors and an additional 6,800,000 warrants by other holders, raising GBP79,800 and increasing the total issued ordinary shares to 1,521,110,997 upon admission expected around April 9, 2026. Furthermore, the company granted 130,000,000 share options to employees, advisers, and directors at an exercise price of 0.95 pence, representing a premium to the previous day's closing price, to incentivize long-term growth. These new options replace all previously held options by directors and management.
Disclaimer*
Arkle Resources PLC
02 April 2026
2 April 2026
Arkle Resources PLC
("Arkle" or the "Company")
Exercise of Warrants,
Director/PDMR Shareholdings
&
Grant of Share Options
Arkle Resources PLC (LSE:ARK), the energy metals explorer with a key focus on uranium, announces that 16,000,000 warrants over ordinary shares of EUR0.0025 each ("Ordinary Shares") with an exercise price of 0.35 pence per share have been exercised by Directors of the Company ("Director Shares") as set out below.
Director Warrant Exercises
Director
Position
No. Warrants Exercised
Resultant Shareholding
Resultant % Ownership
*
John Teeling
Executive Chairman
10,000,000
73,718,035
4.85
David Cockbill
Non-Executive Director
6,000,000
35,893,741
2.36
*
Of enlarged issued share capital, post Admission of the Director Shares and Other Shares
A further 6,800,000 warrants over Ordinary Shares with an exercise price of 0.35 pence per share have been exercised by other warrant holders ("Other Shares").
Application has been made for the Director Shares and the Other Shares, which will rank pari passu with the existing Ordinary Shares, to be admitted to trading on AIM and it is expected that this will take place at 8.00 a.m. on or around 9 April 2026 ("Admission"). The Company has received the proceeds of the warrant exercises of GBP79,800.
Total Voting Rights
Following Admission, Arkle will have 1,521,110,997 Ordinary Shares in issue which will also represent the total number of voting rights in the Company. The above figure should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
Grant of Share Options
Arkle also announces the grant of share options over 130,000,000 Ordinary Shares to certain key employees, advisers, consultants and directors, with an exercise price of 0.95 pence, approximately a 65% premium to the Company's closing share price on 1 April 2026, (the "Options"), to
incentivise long-term growth reflected in the Company's valuation. The Options vest immediately and are valid for a period of five years. The vesting criteria requires the recipient to remain engaged by the Company at the time of exercise. These new Options replace all options previously held by directors and management which have been cancelled.
Schedule of Director/PDMR & Adviser/Consultant Options
Director
Position
No. Options Granted
John Teeling
Executive Chairman
10,000,000
Rory Harding
Director, Interim CEO
45,000,000
James Finn
Financial Director & Co. Secretary
10,000,000
David Cockbill
Non-Executive Director
15,000,000
Robin Birchall
Non-Executive Director
10,000,000
Mark Burnett
Strategic Adviser & Board Observer
20,000,000
Chris Healey
Chief Geologist
5,000,000
Aron Haludilu
Country Manager, Namibia
10,000,000
TOTAL
125,000,000
The remaining 5,000,000 Options are being awarded to a consultant on the same terms as described above.
Contacts:
Arkle Resources
Rory Harding, Interim CEO
John Teeling, Chairman
+44 (0)20 3051 5348
+353 (0) 1 833 2833
SP Angel Corporate Finance
Matthew Johnson
Charlie Bouverat
Adam Cowl
Nominated Adviser & Joint Broker
+44 (0)20 3470 0470
First Equity Limited
Jason Robertson
Joint Broker
+44 (0)20 7374 2212
Vigo Consulting
UK Media & IR
Ben Simons
Seb Weller
+44 (0)20 7390 0234
arkle.ir@vigoconsulting.com
Teneo
Luke Hogg
Molly Mooney
Ireland Media
+353 (0) 1 661 4055
About Arkle Resources
Arkle Resources PLC (LSE:ARK) is a multi-commodity exploration company focused on metals which are essential for the generation and storage of clean energy - uranium, lithium and zinc. Its projects are in premier mining jurisdictions in Namibia, Botswana and Ireland, adjacent to world-class deposits.
Founded in 2004 by John Teeling and Jim Finn, the Company co-discovered the Stonepark zinc deposit in County Limerick - now Ireland's second largest undeveloped resource - in joint venture with Teck Ireland. Teck's interest was acquired by Group Eleven Resources (TSX-V: ZNG), who continue to advance the project alongside Arkle.
In January 2026, the Company announced a transformative deal to acquire Namibia Uranium, which has introduced four highly prospective uranium licences contiguous to major producing and development assets in what is a world-class uranium jurisdiction.
This acquisition, alongside the Company's existing licence portfolio and the introduction of new management, repositions Arkle to become a leading explorer in energy metals.
For more information visit:
www.arkleresources.com
Follow us on social media:
www.x.com/ArkleResources
www.linkedin.com/company/arkle-resources-plc
The person who arranged for the release of this announcement on behalf of the Company was Jim Finn, Director.
A copy of this announcement is available on the Company's website at:
www.arkleresources.com
.
Market Abuse Regulation (MAR) Disclosure
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.
APPENDIX
The information set out below is provided in accordance with the requirements of Article 19(3) of UK MAR.
1.
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
1.    John Teeling
2.    David Cockbill
2.
Reason for the Notification
a)
Position/status
1.    Executive Chairman
2.    Non-Executive Director
b)
Initial notification / Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Arkle Resources plc
b)
LEI
213800CTOO8MOLMNEQ44
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the Financial instrument, type of instrument
Ordinary Shares of EUR0.0025 each
Identification Code
IE00B2357X72
b)
Nature of the transaction
Exercise of Warrants
c)
Price(s) and volume(s)
1.    10,000,000 at 0.35 pence
2.    6,000,000 at 0.35 pence
d)
Aggregated information:
· Aggregated volume
· Price
1.    10,000,000 at 0.35 pence
2.    6,000,000 at 0.35 pence
e)
Date of the transaction
1 April 2026
f)
Place of the Transaction
London Stock Exchange
1.
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
3.    John Teeling
4.    Rory Harding
5.    James Finn
6.    David Cockbill
7.    Robin Birchall
8.    Mark Burnett
9.    Chris Healey
10.
Aron Haludilu
2.
Reason for the Notification
a)
Position/status
3.    Executive Chairman
4.    Director, Interim CEO
5.    Director, Financial Director & Co. Secretary
6.    Non-Executive Director
7.    Non-Executive Director
8.    Strategic Adviser & Board Observer
9.    Chief Geologist
10.  Country Manager, Namibia
b)
Initial notification / Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Arkle Resources plc
b)
LEI
213800CTOO8MOLMNEQ44
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the Financial instrument, type of instrument
Ordinary Shares of EUR0.0025 each
Identification Code
IE00B2357X72
b)
Nature of the transaction
Grant of Options
c)
Price(s) and volume(s)
Exercise price - 0.95 pence
1.    10,000,000
2.    45,000,000
3.    10,000,000
4.    15,000,000
5.    10,000,000
6.    20,000,000
7.    5,000,000
8.    10,000,000
d)
Aggregated information:
· Aggregated volume
· Price
1.    10,000,000
2.    45,000,000
3.    10,000,000
4.    15,000,000
5.    10,000,000
6.    20,000,000
7.    5,000,000
8.
10,000,000
Exercise price - 0.95 pence
e)
Date of the transaction
1 April 2026
f)
Place of the Transaction
Off market
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com
or visit
www.rns.com
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy
.
END
AI Summary Disclaimer BETA
×
The content you are viewing has been generated or assisted by artificial intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may contain inaccuracies, outdated information, or subjective interpretations. This content is intended for general informational purposes only and should not be considered professional advice or factual confirmation.
We encourage you to independently verify any information provided, especially if it will be relied upon for making decisions or taking action. Any reliance you place on this material is strictly at your own risk. The AI system that produced this content cannot assess the specifics of individual circumstances, and results may vary based on context and individual needs.
Companies
Arkle Resources (CDI) (ARK)
UK 100
FTSE quotes
by TradingView
▶
🔊
Latest directors dealings
4 minutes ago
M&G
4 minutes ago
Centrica
20 minutes ago
PayPoint
34 minutes ago
The Schiehallion Fund Limited NPV
34 minutes ago
Anglo American
All directors dealings today
All intraday prices are subject to a delay of fifteen (15) minutes.
Investegate takes no responsibility for the accuracy of the information within this site.
The announcements are supplied by the denoted source. Queries about the content of an announcement should be directed to the source. Investegate reserves the right to publish a filtered set of announcements. NAV, EMM/EPT, Rule 8 and FRN Variable Rate Fix announcements are filtered from this site.
© 2026 Stockomendation Ltd
Privacy and Cookie Policy
Terms
Acceptable Use Policy
Investors
Advertise with Us
Other Stockomendation sites
Stockomendation
UK Share Picking Game
This website is for Private Investors*
I am a Private Investor
*A
Private Investor
is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our
Privacy and Cookie Policy
&
Terms
.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Sign Up
Log In
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.
Complete Profile